Fingolimod Capsules

The Defense Logistics Agency (DLA) intends to issue a solicitation for a national requirements contract to supply Fingolimod 0.5MG capsules in 30-count bottles. This procurement will be unrestricted and fully competitive, structured as a firm-fixed price, requirements-type contract with a one-year base period and four one-year option periods. The contract aims to establish a national supply source for these capsules, supporting purchases by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. Annual usage estimates will be provided within the solicitation's Schedule of Supplies, and the acquisition will be conducted as a commercial item under FAR part 12. All interested sources are eligible to submit proposals to be considered. The solicitation, identified by number SPE2D2-26-R-0007, is projected to be released around April 2026 but may be issued earlier or later at DLA's discretion. The contract falls under the NAICS code 325412 and will be managed by DLA Troop Support located in Philadelphia, PA. Interested parties are encouraged to monitor updates and set up automated notifications via the DLA Bid Board System (DIBBS) and SAM.gov. Primary and secondary points of contact for inquiries are Henry Shelly and Jason Wray, respectively, ensuring that vendors can address questions or submit comments in a timely manner.